143 related articles for article (PubMed ID: 17709599)
61. Angiotensin II Increases Endoplasmic Reticulum Stress in Adipose Tissue and Adipocytes.
Menikdiwela KR; Ramalingam L; Allen L; Scoggin S; Kalupahana NS; Moustaid-Moussa N
Sci Rep; 2019 Jun; 9(1):8481. PubMed ID: 31186446
[TBL] [Abstract][Full Text] [Related]
62. Dimerized translationally controlled tumor protein increases interleukin-8 expression through MAPK and NF-κB pathways in a human bronchial epithelial cell line.
Lee H; Lee K
Cell Biosci; 2018; 8():13. PubMed ID: 29484169
[TBL] [Abstract][Full Text] [Related]
63. High-Dose Ibuprofen in Cystic Fibrosis.
Lands LC; Dauletbaev N
Pharmaceuticals (Basel); 2010 Jul; 3(7):2213-2224. PubMed ID: 27713350
[TBL] [Abstract][Full Text] [Related]
64. C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease.
Liu SH; Wu CT; Huang KH; Wang CC; Guan SS; Chen LP; Chiang CK
Oncotarget; 2016 Apr; 7(16):21900-12. PubMed ID: 26942460
[TBL] [Abstract][Full Text] [Related]
65. Altered Expression of Endoplasmic Reticulum Stress Associated Genes in Hippocampus of Learned Helpless Rats: Relevance to Depression Pathophysiology.
Timberlake MA; Dwivedi Y
Front Pharmacol; 2015; 6():319. PubMed ID: 26793110
[TBL] [Abstract][Full Text] [Related]
66. Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease.
Jundi K; Greene CM
Biomolecules; 2015 Jul; 5(3):1386-98. PubMed ID: 26140537
[TBL] [Abstract][Full Text] [Related]
67. Quercetin ameliorates tunicamycin-induced endoplasmic reticulum stress in endothelial cells.
Suganya N; Bhakkiyalakshmi E; Suriyanarayanan S; Paulmurugan R; Ramkumar KM
Cell Prolif; 2014 Jun; 47(3):231-40. PubMed ID: 24666891
[TBL] [Abstract][Full Text] [Related]
68. Modulation of proinflammatory activity by the engineered cationic antimicrobial peptide WLBU-2.
Paranjape SM; Lauer TW; Montelaro RC; Mietzner TA; Vij N
F1000Res; 2013; 2():36. PubMed ID: 24555033
[TBL] [Abstract][Full Text] [Related]
69. Improving cytocompatibility of Co28Cr6Mo by TiO2 coating: gene expression study in human endothelial cells.
Tsaryk R; Peters K; Unger RE; Feldmann M; Hoffmann B; Heidenau F; Kirkpatrick CJ
J R Soc Interface; 2013 Sep; 10(86):20130428. PubMed ID: 23825117
[TBL] [Abstract][Full Text] [Related]
70. Epithelial morphogenesis of MDCK cells in three-dimensional collagen culture is modulated by interleukin-8.
Wells EK; Yarborough O; Lifton RP; Cantley LG; Caplan MJ
Am J Physiol Cell Physiol; 2013 May; 304(10):C966-75. PubMed ID: 23485708
[TBL] [Abstract][Full Text] [Related]
71. NF-κB-dependent IL-8 induction by prostaglandin E(2) receptors EP(1) and EP(4).
Neuschäfer-Rube F; Pathe-Neuschäfer-Rube A; Hippenstiel S; Kracht M; Püschel GP
Br J Pharmacol; 2013 Feb; 168(3):704-17. PubMed ID: 22924768
[TBL] [Abstract][Full Text] [Related]
72. Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociates obesity from insulin resistance.
Maris M; Overbergh L; Gysemans C; Waget A; Cardozo AK; Verdrengh E; Cunha JP; Gotoh T; Cnop M; Eizirik DL; Burcelin R; Mathieu C
Diabetologia; 2012 Apr; 55(4):1167-78. PubMed ID: 22237685
[TBL] [Abstract][Full Text] [Related]
73. Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.
Dauletbaev N; Eklove D; Mawji N; Iskandar M; Di Marco S; Gallouzi IE; Lands LC
J Biol Chem; 2011 May; 286(18):15998-6007. PubMed ID: 21454676
[TBL] [Abstract][Full Text] [Related]
74. Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema.
Min T; Bodas M; Mazur S; Vij N
J Mol Med (Berl); 2011 Jun; 89(6):577-93. PubMed ID: 21318260
[TBL] [Abstract][Full Text] [Related]
75. PKR-dependent CHOP induction limits hyperoxia-induced lung injury.
Lozon TI; Eastman AJ; Matute-Bello G; Chen P; Hallstrand TS; Altemeier WA
Am J Physiol Lung Cell Mol Physiol; 2011 Mar; 300(3):L422-9. PubMed ID: 21186267
[TBL] [Abstract][Full Text] [Related]
76. Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis.
Vij N; Min T; Marasigan R; Belcher CN; Mazur S; Ding H; Yong KT; Roy I
J Nanobiotechnology; 2010 Sep; 8():22. PubMed ID: 20868490
[TBL] [Abstract][Full Text] [Related]
77. Linoleic acid supplement in cystic fibrosis: friend or foe?
Vij N
Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L597-8. PubMed ID: 20709729
[No Abstract] [Full Text] [Related]
78. The NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential.
Bodas M; Vij N
Discov Med; 2010 Apr; 9(47):346-56. PubMed ID: 20423679
[TBL] [Abstract][Full Text] [Related]
79. Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.
Belcher CN; Vij N
Curr Mol Med; 2010 Feb; 10(1):82-94. PubMed ID: 20205681
[TBL] [Abstract][Full Text] [Related]
80. Ibuprofen: pharmacology, efficacy and safety.
Rainsford KD
Inflammopharmacology; 2009 Dec; 17(6):275-342. PubMed ID: 19949916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
